[1] Pokra, M., Sharma, D. K., Mehta, P., Verma, H. R., Pundir, S., Rana, J., & Kulmi, D. (2016). Its alarming, Klebsiella spp. towards multidrug resistance. Int J Curr Microbiol App Sci, 5(6), 150-60.
[2] Yadegarynia, D., Karimi, J., Rahmati Roodsari, S., & Arab-Mazar, Z. (2017). Evaluation of the antimicrobial resistance of Klebsiella pneumoniae by E-Test method in Khatam_ol_Anbia Hospital, Tehran, Iran, during 2015. Infection Epidemiology and Microbiology, 3(1), 9-11.
[3] Ahmed, R. Z. T., Hadi, T. F., & Abdullah, R. M. (2020). Bacteriological and Molecular study of Klebsiella pneumoniae isolated from patients with urinary tract infections from several hospitals in Baghdad. Medico Legal Update, 20(4), 2049-2055.
[4] Ko, K. S. (2017). The contribution of capsule polysaccharide genes to virulence of Klebsiella pneumoniae. Virulence, 8(5), 485-486.
[5] Struve, C., & Krogfelt, K. A. (2003). Role of capsule in Klebsiella pneumoniae virulence: lack of correlation between in vitro and in vivo studies. FEMS microbiology letters, 218(1), 149-154.
[6] Peng, D., Li, X., Liu, P., Zhou, X., Luo, M., Su, K.,… & Li, Y. (2018). Transcriptional regulation of galF by RcsAB affects capsular polysaccharide formation in Klebsiella pneumoniae NTUH-K2044. Microbiological research, 216, 70-78.
[7] Fang, C. T., Chuang, Y. P., Shun, C. T., Chang, S. C., & Wang, J. T. (2004). A novel virulence gene in Klebsiella pneumoniae strains causing primary liver abscess and septic metastatic complications. The Journal of experimental medicine, 199(5), 697-705.
[8] Roberts, I. S. (1996). The biochemistry and genetics of capsular polysaccharide production in bacteria. Annual review of microbiology, 50(1), 285-315.
[9] Balestrino, D., Ghigo, J. M., Charbonnel, N., Haagensen, J. A., & Forestier, C. (2008). The characterization of functions involved in the establishment and maturation of Klebsiella pneumoniae in vitro biofilm reveals dual roles for surface exopolysaccharides. Environmental microbiology, 10(3), 685-701.
[10] Vuotto, C., Longo, F., Pascolini, C., Donelli, G., Balice, M. P., Libori, M. F.,... & Varaldo, P. E. (2017). Biofilm formation and antibiotic resistance in Klebsiella pneumoniae urinary strains. Journal of applied microbiology, 123(4), 1003-1018.
[11] Shah, R. K., Ni, Z. H., Sun, X. Y., Wang, G. Q., & Li, F. (2017). The determination and correlation of various virulence genes, ESBL, serum bactericidal effect and biofilm formation of clinical isolated classical and hypervirulent from respiratory tract infected patients. Polish journal of microbiology, 66(4), 501-508.
[12] Anderl, J. N., Zahller, J., Roe, F., & Stewart, P. S. (2003). Role of nutrient limitation and stationary-phase existence in Klebsiella pneumoniae biofilm resistance to ampicillin and ciprofloxacin. Antimicrobial agents and chemotherapy, 47(4), 1251-1256.
[13] Hennequin, C., Aumeran, C., Robin, F., Traore, O., & Forestier, C. (2012). Antibiotic resistance and plasmid transfer capacity in biofilm formed with a CTX-M-15-producing Klebsiella pneumoniae isolate. Journal of Antimicrobial Chemotherapy, 67(9), 2123-2130.
[14] Clegg, S., & Murphy, C. N. (2017). Epidemiology and virulence of Klebsiella pneumoniae. Urinary Tract Infections: Molecular Pathogenesis and Clinical Management, 435-457.
[15] Ares, M. A., Sansabas, A., Rodríguez-Valverde, D., Siqueiros-Cendón, T., Rascón-Cruz, Q., Rosales-Reyes, R.,... & De la Cruz, M. A. (2019). The interaction of Klebsiella pneumoniae with lipid rafts-associated cholesterol increases macrophage-mediated phagocytosis due to down regulation of the capsule polysaccharide. Frontiers in Cellular and Infection Microbiology, 9, 255.
[16] Walker, K. A., & Miller, V. L. (2020). The intersection of capsule gene expression, hypermucoviscosity and hypervirulence in Klebsiella pneumoniae. Current opinion in microbiology, 54, 95-102.
[17] Rahn, A., & Whitfield, C. (2003). Transcriptional organization and regulation of the Escherichia coli K30 group 1 capsule biosynthesis (cps) gene cluster. Molecular microbiology, 47(4), 1045-1060.
[18] Rahn, A., Beis, K., Naismith, J. H., & Whitfield, C. (2003). A novel outer membrane protein, Wzi, is involved in surface assembly of the Escherichia coli K30 group 1 capsule. Journal of bacteriology, 185(19), 5882-5890.
[19] Bialek-Davenet, S., Criscuolo, A., Ailloud, F., Passet, V., Nicolas-Chanoine, M. H., Decré, D., & Brisse, S. (2014). Development of a multiplex PCR assay for identification of Klebsiella pneumoniae hypervirulent clones of capsular serotype K2. Journal of medical microbiology, 63(12), 1608-1614.
[20] Zhu, J., Wang, T., Chen, L., & Du, H. (2021). Virulence factors in hypervirulent Klebsiella pneumoniae. Frontiers in microbiology, 12, 642484.
[21] Whitfield, C. (2006). Biosynthesis and assembly of capsular polysaccharides in Escherichia coli. Annu. Rev. Biochem., 75(1), 39-68.
[22] Lin, T. H., Huang, S. H., Wu, C. C., Liu, H. H., Jinn, T. R., Chen, Y., & Lin, C. T. (2013). Inhibition of
Klebsiella pneumoniae growth and capsular polysaccharide biosynthesis by Fructus mume.
Evidence‐Based Complementary and Alternative Medicine,
2013(1), 621701.
[23] Wang, W., Tian, D., Hu, D., Chen, W., Zhou, Y., & Jiang, X. (2023). Different regulatory mechanisms of the capsule in hypervirulent Klebsiella pneumonia:“direct” wcaJ variation vs.“indirect” rmpA regulation. Frontiers in Cellular and Infection Microbiology, 13, 1108818.
[24] Walker, K. A., Miner, T. A., Palacios, M., Trzilova, D., Frederick, D. R., Broberg, C. A.,... & Miller, V. L. (2019). A Klebsiella pneumoniae regulatory mutant has reduced capsule expression but retains hypermucoviscosity. MBio, 10(2), 10-1128.
[25] Jensen, S. O., & Reeves, P. R. (2001). Molecular evolution of the GDP-mannose pathway genes (manB and manC) in Salmonella enterica. Microbiology, 147(3), 599-610.
[26] Al-Fahdawi, A. M., Zylstra, G. J., & Mutter, T. Y. (2023). Molecular and phenotypic detection of siderophore production by hypervirulent Klebsiella pneumoniae. Journal of University of Anbar for Pure Science, 17(2).
[27] Wanger, A., & Chávez, V. (2021). Antibiotic susceptibility testing. In Practical Handbook of Microbiology (pp. 119-128). CRC Press.
[28] Mccallum, K. L., & Whitfield, C. H. R. I. S. (1991). The rcsA gene of Klebsiella pneumoniae O1: K20 is involved in expression of the serotype-specific K (capsular) antigen. Infection and immunity, 59(2), 494-502.
[29] Paczosa, M. K., & Mecsas, J. (2016). Klebsiella pneumoniae: going on the offense with a strong defense. Microbiology and molecular biology reviews, 80(3), 629-661.
[30] Al-Timimi, S. (2021). Persistence, and filaments formation in Klebsiella pneumoniae clinical Isolates (Doctoral dissertation, M. Sc. thesis. College of science. Mustansiriyah university).
[31] Mobarak-Qamsari, M., Ashayeri-Panah, M., Eftekhar, F., & Feizabadi, M. M. (2013). Integron mediated multidrug resistance in extended spectrum beta-lactamase producing clinical isolates of Klebsiella pneumoniae. Brazilian journal of microbiology, 44, 849-854.
[32] Lawlor, M. S., Hsu, J., Rick, P. D., & Miller, V. L. (2005). Identification of Klebsiella pneumoniae virulence determinants using an intranasal infection model. Molecular microbiology, 58(4), 1054-1073.
[33] Pal, S., Verma, J., Mallick, S., Rastogi, S. K., Kumar, A., & Ghosh, A. S. (2019). Absence of the glycosyltransferase WcaJ in Klebsiella pneumoniae ATCC13883 affects biofilm formation, increases polymyxin resistance and reduces murine macrophage activation. Microbiology, 165(8), 891-904.
[34] Struve, C., Bojer, M., & Krogfelt, K. A. (2008). Characterization of Klebsiella pneumoniae type 1 fimbriae by detection of phase variation during colonization and infection and impact on virulence. Infection and immunity, 76(9), 4055-4065.
[35] Yang, D., & Zhang, Z. (2008). Biofilm-forming Klebsiella pneumoniae strains have greater likelihood of producing extended-spectrum β-lactamases, J. Hosp. Infect, 68, 369–371.
[36] Subramanian, P., Shanmugam, N., Sivaraman, U., Kumar, S., & Selvaraj, S. (2012). Antiobiotic resistance pattern of biofilm-forming uropathogens isolated from catheterised patients in Pondicherry, India. The Australasian medical journal, 5(7), 344.
[37] Dzul, S. P., Thornton, M. M., Hohne, D. N., Stewart, E. J., Shah, A. A., Bortz, D. M.,... & Younger, J. G. (2011). Contribution of the Klebsiella pneumoniae capsule to bacterial aggregate and biofilm microstructures. Applied and environmental microbiology, 77(5), 1777-1782.
[38] Khaleel, D. S., Mutter, T. Y., & Huang, X. (2024). Potential mechanism of gallic acid‐coated iron oxide nanoparticles against associated genes of Klebsiella pneumoniae capsule, antibacterial and antibiofilm. Microscopy Research and Technique, 87(11), 2774-2784.
[39] Al-Fahdawi, A. M., Mutter, T. Y., & Zylstra, G. J. (2023). Genotypic identification of hypervirulent Klebsiella pneumoniae in Anbar, Iraq. Malaysian Journal of Microbiology, 19(5).
[40] Ahmed, A. J. A., & Alaa, H. A. A. (2016). Virulence factors and antibiotic susceptibility patterns of multidrug resistance Klebsiella pneumoniae isolated from different clinical infections. African Journal of Microbiology Research, 10(22), 829-843.